Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lemon

Showing results (481-490 of 515) with videos related to

Pageof 52
Sort By:
Nature Medicine|February 1, 1996
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitisA D Weinberg, D N Bourdette, T J Sullivan, et al.
Mbio|September 7, 2017
TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A VirionsAnshuman Das, Asuka Hirai-Yuki, Olga González-López, et al.
Antimicrobial Agents and Chemotherapy|August 6, 2014
Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfectionCassandra B Jabara, Fengyu Hu, Katie R Mollan, et al.
Journal of Virology|January 17, 2014
Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzeeMinKyung Yi, Fengyu Hu, Michael Joyce, et al.
Plos Pathogens|September 30, 2021
IRF3-mediated pathogenicity in a murine model of human hepatitis ALu Sun, You Li, Ichiro Misumi, et al.
Journal of Virology|May 6, 2011
Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment stepMichelle C Sabo, Vincent C Luca, Jannick Prentoe, et al.
Nucleic Acids Research|April 24, 2023
CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signalingMoe Matsumoto, Jennifer L Modliszewski, Kotomi Shinozaki, et al.
Plos Pathogens|April 19, 2012
Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolateZhen-yong Keck, Jinming Xia, Yong Wang, et al.
Journal of Hepatology|September 24, 2022
Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infectionLu Sun, Hui Feng, Ichiro Misumi, et al.
The Journal of Biological Chemistry|December 15, 2005
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutationsMinKyung Yi, Xiao Tong, Angela Skelton, et al.
Pageof 52

Showing results (481-490 of 515) with videos related to

Sort By:
Pageof 52
Nature Medicine|February 1, 1996
Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitisA D Weinberg, D N Bourdette, T J Sullivan, et al.
Mbio|September 7, 2017
TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A VirionsAnshuman Das, Asuka Hirai-Yuki, Olga González-López, et al.
Antimicrobial Agents and Chemotherapy|August 6, 2014
Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfectionCassandra B Jabara, Fengyu Hu, Katie R Mollan, et al.
Journal of Virology|January 17, 2014
Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzeeMinKyung Yi, Fengyu Hu, Michael Joyce, et al.
Plos Pathogens|September 30, 2021
IRF3-mediated pathogenicity in a murine model of human hepatitis ALu Sun, You Li, Ichiro Misumi, et al.
Journal of Virology|May 6, 2011
Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment stepMichelle C Sabo, Vincent C Luca, Jannick Prentoe, et al.
Nucleic Acids Research|April 24, 2023
CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signalingMoe Matsumoto, Jennifer L Modliszewski, Kotomi Shinozaki, et al.
Plos Pathogens|April 19, 2012
Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolateZhen-yong Keck, Jinming Xia, Yong Wang, et al.
Journal of Hepatology|September 24, 2022
Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infectionLu Sun, Hui Feng, Ichiro Misumi, et al.
The Journal of Biological Chemistry|December 15, 2005
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutationsMinKyung Yi, Xiao Tong, Angela Skelton, et al.
Pageof 52